Litigation Details for Alkermes Pharma Ireland Limited v. Luye Pharma Group Ltd. (D. Del. 2019)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2019-07-17
Court	District Court, D. Delaware	Date Terminated	2019-12-02
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Parties	NANJING LUYE PHARMACEUTICAL CO., LTD.
Patents	6,667,061
Attorneys	Scott A. Cunning , II
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

The small molecule drugs covered by the patent cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2019-07-17	1	Complaint	infringement of United States Patent No. 6,667,061 (“the ’061 patent”) under the Patent Laws of the United States…infringed one or more claims of United States Patent No. 6,667,061 by submitting NDA No. 212849 seeking FDA… before the expiration of United States Patent No. 6,667,061 including any extensions and additional…infringe one or more claims of United States Patent No. 6,667,061 under 35 U.S.C. §§ 271(a), (b), and/or (…day after the expiration of United States Patent No. 6,667,061, inclusive of any extensions or additional	External link to document
2019-07-17	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,667,061 B2. (sam) (Entered:…2019 3 December 2019 1:19-cv-01340 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-11-21	58	Stipulation of Dismissal	Defendants”) for infringement of U.S. Patent No. 6,667,061 (the “Patent” and such action, the “Litigation”…DISMISSAL WHEREAS, this action for patent infringement has been brought by Plaintiffs Alkermes…2019 3 December 2019 1:19-cv-01340 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document